Fortress Biotech Inc's Customers Performance

Name: Fortress Biotech Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

FBIO

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


FBIO's Source of Revenues		During the corresponding time, Fortress Biotech Inc recorded a revenue increase by 25.66 % year on year, sequentially revenue grew by 16.71 %. While revenue at the Fortress Biotech Inc 's corporate clients • List of FBIO Customers

for the same period Fortress Biotech Inc recorded revenue increase by 25.66 % year on year, sequentially revenue grew by 16.71 %.

• List of FBIO Customers

Fortress Biotech Inc's Business Units


Journey	99.52 %	of total Revenue
Fortress	0.48 %	of total Revenue
Emrosi	38.98 %	of total Revenue
Qbrexza	31.35 %	of total Revenue
Accutane	20.66 %	of total Revenue
Foam franchise products Amzeeq Zilxi	6.55 %	of total Revenue
Other legacy product revenue	1.73 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Fortress Biotech Inc's Comment on Sales, Marketing and Customers

News about Fortress Biotech Inc Contracts

Triplex: A Promising Breakthrough in CMV Control for Liver Transplant Patients

Cytomegalovirus (CMV) is a significant concern in patients undergoing liver transplantation, as it poses a serious threat to both graft and patient survival. In light of this challenge, Fortress Biotech s majority-owned subsidiary, Helocyte, has commenced a groundbreaking Phase 2 study utilizing Triplex, a novel preventive and therapeutic approach for the effective management of CMV and other transplant-related infections. This article delves into the implications of Triplex in liver transplant recipients and its potential to revolutionize the field of transplantation medicine.Combatting CMV in Transplantation:CMV infection is a common complication following liver transplantation and can lead to various life...

FBIO's Stock Performance relative to it's Customers

FBIO's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Fortress Biotech Inc	86.47	66.16	128.94	78
SUBTOTAL	0.00	0.00	0.00	-

Sources: Fortress Biotech Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Fortress Biotech Inc’s corporate clients.
For your research, we’ve provided 9 tables on Fortress Biotech Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.